To test this idea, we treated transgenic mice overexpressing the familial ALS-associated G93A SOD1 mutation (mSOD1G93A mice) with R723, an orally active inhibitor of JAK2 [15]. Here, JAK2 is linked to amyotrophic lateral sclerosis.